NCT07296484

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2025-11-29Est. Completion: 2027-12-31

Enrollment target: 1,500 participants

Locations

Arizona Clinical Trials - Pecos, Chandler, Arizona, United States
Arizona Clinical Trials - Broadway, Tucson, Arizona, United States
Ark Clinical Research - Fountain Valley, Fountain Valley, California, United States
Velocity Clinical Research, Huntington Park, Huntington Park, California, United States
Velocity Clinical Research - Gardena, La Mesa, California, United States
Ark Clinical Research - Long Beach, Long Beach, California, United States
Los Angeles Institute for Metabolic Research, Los Angeles, California, United States
Velocity Clinical Research, Los Angeles, Los Angeles, California, United States
Amicis Research Center- Nordhoff, Northridge, California, United States
Alliance Clinical San Diego, San Diego, California, United States
Velocity Clinical Research, New Smyrna Beach, Edgewater, Florida, United States
The Center for Diabetes and Endocrine Care, Fort Lauderdale, Florida, United States
Admed Research LLC, Miami, Florida, United States
Suncoast Clinical Research, Inc, New Port Richey, Florida, United States

Inflammatory Bowel DiseaseCrohn's DiseaseUlcerative Colitis

Background: Inflammatory bowel disease (IBD) is a term used to describe disorders that cause long-term inflammation in …

Bethesda, United StatesEst. completion Jun 1, 2036

Type 2 Diabetes Mellitus (T2DM)

This randomized controlled trial will evaluate the effect of digital-supported foot care education on foot care knowledg…

Siirt, Turkey (Türkiye)Est. completion Jul 15, 2027

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.